Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Biosimilars are alternatives to existing patented and approved biologics that have similar medicinal properties compared to the original biologics. Biosimilars are slightly different in structure from the original biosimilars but must have similar safety and efficacy profiles compared to the original biosimilars.
The market for biosimilars is characterized by a large number of pharmaceutical giants and emerging enterprises all over the world. Europe region is expected to lead the global market owing to the presence of many major players in the region. The global Biosimilars market is expected to reach USD 44.56 Billion by year 2026, at a CAGR of 28.7%.
The global biosimilars market is driven by factors such as the global prevalence of target disease prevalence across the globe, the launch of biosimilars by various market players, and favorable investments scenario. However, risks to drug efficacy and stringent government regulations are expected to adversely affect market growth.
This report offers an overview of the market trends, drivers, and barriers with respect to the USA Biosimilars market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Biosimilars market. Detailed analysis of key players, along with key growth strategies adopted by Biosimilars industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.
By Player:
Sandoz International
Mylan
Hospira
Roche Diagnostics
Biocon
Amgen
Celltrion
Merck KGaA
Teva Pharmaceutical
By Type:
Injection
Tablets
Others
By End-User:
Ankylosing Spondylitis
Tumor
Rheumatoid Arthrtis
Cardiovascular
By Region:
-
West USA
-
South USA
-
Middle West USA
-
Northeast USA
TABLE OF CONTENT
1 Report Overview
-
1.1 Product Definition and Scope
-
1.2 PEST (Political, Economic, Social and Technological) Analysis of Biosimilars Market
-
1.3 Market Segment by Type
-
1.3.1 USA Biosimilars Market Size and Growth Rate of Injection from 2016 to 2027
-
1.3.2 USA Biosimilars Market Size and Growth Rate of Tablets from 2016 to 2027
-
1.3.3 USA Biosimilars Market Size and Growth Rate of Others from 2016 to 2027
-
1.4 Market Segment by Application
-
1.4.1 USA Biosimilars Market Size and Growth Rate of Ankylosing Spondylitis from 2016 to 2027
-
1.4.2 USA Biosimilars Market Size and Growth Rate of Tumor from 2016 to 2027
-
1.4.3 USA Biosimilars Market Size and Growth Rate of Rheumatoid Arthrtis from 2016 to 2027
-
1.4.4 USA Biosimilars Market Size and Growth Rate of Cardiovascular from 2016 to 2027
-
1.5 Market Segment by Regions
-
1.5.1 West USA Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.2 South USA Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.3 Middle West USA Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
1.5.4 Northeast USA Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
2 Market Trends and Competitive Landscape
-
2.1 Market Trends and Dynamics
-
2.1.1 Market Challenges and Restraints
-
2.1.2 Market Opportunities and Potentials
-
2.1.3 Mergers and Acquisitions
-
2.2 Competitive Landscape Analysis
-
2.2.1 Industrial Concentration Analysis
-
2.2.2 Porter's Five Forces Analysis of the Industry
-
2.2.3 SWOT Analysis for New Entrants
-
2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry
3 Segmentation of Biosimilars Market by Types
-
3.1 Products Development Trends of Different Types
-
3.2 Products Types of Major Vendors
-
3.3 Competitive Landscape Analysis of Different Types
-
3.4 Market Size of Biosimilars by Major Types
-
3.4.1 Market Size and Growth Rate of Injection
-
3.4.2 Market Size and Growth Rate of Tablets
-
3.4.3 Market Size and Growth Rate of Others
4 Segmentation of Biosimilars Market by End-Users
-
4.1 Downstream Client Analysis by End-Users
-
4.2 Competitive Landscape Analysis of Different End-Users
-
4.3 Market Potential Analysis of Different End-Users
-
4.4 Market Size of Biosimilars by Major End-Users
-
4.4.1 Market Size and Growth Rate of Biosimilars in Ankylosing Spondylitis
-
4.4.2 Market Size and Growth Rate of Biosimilars in Tumor
-
4.4.3 Market Size and Growth Rate of Biosimilars in Rheumatoid Arthrtis
-
4.4.4 Market Size and Growth Rate of Biosimilars in Cardiovascular
5 Market Analysis by Regions
-
5.1 USA Biosimilars Production Analysis by Regions
-
5.2 USA Biosimilars Consumption Analysis by Regions
-
5.3 Coronavirus (COVID-19) Impact on USA Economy
6 West USA Biosimilars Landscape Analysis
-
6.1 West USA Biosimilars Landscape Analysis by Major Types
-
6.2 West USA Biosimilars Landscape Analysis by Major End-Users
7 South USA Biosimilars Landscape Analysis
-
7.1 South USA Biosimilars Landscape Analysis by Major Types
-
7.2 South USA Biosimilars Landscape Analysis by Major End-Users
8 Middle West USA Biosimilars Landscape Analysis
-
8.1 Middle West USA Biosimilars Landscape Analysis by Major Types
-
8.2 Middle West USA Biosimilars Landscape Analysis by Major End-Users
9 Northeast USA Biosimilars Landscape Analysis
-
9.1 Northeast USA Biosimilars Landscape Analysis by Major Types
-
9.2 Northeast USA Biosimilars Landscape Analysis by Major End-Users
10 Major Players Profiles
-
10.1 Sandoz International
-
10.1.1 Sandoz International Company Profile and Recent Development
-
10.1.2 Market Performance
-
10.1.3 Product and Service Introduction
-
10.2 Mylan
-
10.2.1 Mylan Company Profile and Recent Development
-
10.2.2 Market Performance
-
10.2.3 Product and Service Introduction
-
10.3 Hospira
-
10.3.1 Hospira Company Profile and Recent Development
-
10.3.2 Market Performance
-
10.3.3 Product and Service Introduction
-
10.4 Roche Diagnostics
-
10.4.1 Roche Diagnostics Company Profile and Recent Development
-
10.4.2 Market Performance
-
10.4.3 Product and Service Introduction
-
10.5 Biocon
-
10.5.1 Biocon Company Profile and Recent Development
-
10.5.2 Market Performance
-
10.5.3 Product and Service Introduction
-
10.6 Amgen
-
10.6.1 Amgen Company Profile and Recent Development
-
10.6.2 Market Performance
-
10.6.3 Product and Service Introduction
-
10.7 Celltrion
-
10.7.1 Celltrion Company Profile and Recent Development
-
10.7.2 Market Performance
-
10.7.3 Product and Service Introduction
-
10.8 Merck KGaA
-
10.8.1 Merck KGaA Company Profile and Recent Development
-
10.8.2 Market Performance
-
10.8.3 Product and Service Introduction
-
10.9 Teva Pharmaceutical
-
10.9.1 Teva Pharmaceutical Company Profile and Recent Development
-
10.9.2 Market Performance
-
10.9.3 Product and Service Introduction
The List of Tables and Figures
-
Figure Product Picture
-
Figure USA Biosimilars Market Size and Growth Rate of Injection from 2016 to 2027
-
Figure USA Biosimilars Market Size and Growth Rate of Tablets from 2016 to 2027
-
Figure USA Biosimilars Market Size and Growth Rate of Others from 2016 to 2027
-
Figure Market Share by Type in 2016
-
Figure Market Share by Type in 2020
-
Figure Market Share by Type in 2027
-
Figure USA Biosimilars Market Size and Growth Rate of Ankylosing Spondylitis from 2016 to 2027
-
Figure USA Biosimilars Market Size and Growth Rate of Tumor from 2016 to 2027
-
Figure USA Biosimilars Market Size and Growth Rate of Rheumatoid Arthrtis from 2016 to 2027
-
Figure USA Biosimilars Market Size and Growth Rate of Cardiovascular from 2016 to 2027
-
Figure Market Share by End-User in 2016
-
Figure Market Share by End-User in 2020
-
Figure Market Share by End-User in 2027
-
Figure West USA Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure South USA Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Middle West USA Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Northeast USA Biosimilars Consumption Market Size and Growth Rate from 2016 to 2027
-
Figure Development Trends and Industry Dynamics of Biosimilars Industry
-
Figure Market Challenges and Restraints
-
Figure Market Opportunities and Potentials
-
Table Mergers and Acquisition
-
Figure Market Share of TOP 3 Players in 2019
-
Figure Market Share of TOP 5 Players in 2019
-
Figure Market Share of TOP 6 Players from 2016 to 2020
-
Figure Porter's Five Forces Analysis
-
Figure New Entrant SWOT Analysis
-
Figure Coronavirus (COVID-19) Distribution Map of USA
-
Table Coronavirus (COVID-19) Impact on the Industry
-
Figure Specifications of Different Types of Biosimilars
-
Figure Development Trends of Different Types
-
Table Products Types of Major Vendors
-
Figure Competitive Landscape Analysis of Different Types
-
Table Consumption of Biosimilars by Different Types from 2016 to 2027
-
Table Consumption Share of Biosimilars by Different Types from 2016 to 2027
-
Figure Market Size and Growth Rate of Injection
-
Figure Market Size and Growth Rate of Tablets
-
Figure Market Size and Growth Rate of Others
-
Table Downstream Client Analysis by End-Users
-
Figure Competitive Landscape Analysis of Different End-Users
-
Table Market Potential Analysis of Different End-Users
-
Figure Consumption of Biosimilars by Different End-Users from 2016 to 2027
-
Table Consumption Share of Biosimilars by Different End-Users from 2016 to 2027
-
Figure Market Size and Growth Rate of Ankylosing Spondylitis
-
Figure Market Size and Growth Rate of Tumor
-
Figure Market Size and Growth Rate of Rheumatoid Arthrtis
-
Figure Market Size and Growth Rate of Cardiovascular
-
Table USA Biosimilars Production by Regions
-
Table USA Biosimilars Production Share by Regions
-
Figure USA Biosimilars Production Share by Regions in 2016
-
Figure USA Biosimilars Production Share by Regions in 2021
-
Figure USA Biosimilars Production Share by Regions in 2027
-
Table USA Biosimilars Consumption by Regions
-
Table USA Biosimilars Consumption Share by Regions
-
Figure USA Biosimilars Consumption Share by Regions in 2016
-
Figure USA Biosimilars Consumption Share by Regions in 2021
-
Figure USA Biosimilars Consumption Share by Regions in 2027
-
Table West USA Biosimilars Consumption by Types from 2016 to 2027
-
Table West USA Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure West USA Biosimilars Consumption Share by Types in 2016
-
Figure West USA Biosimilars Consumption Share by Types in 2021
-
Figure West USA Biosimilars Consumption Share by Types in 2027
-
Table West USA Biosimilars Consumption by End-Users from 2016 to 2027
-
Table West USA Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure West USA Biosimilars Consumption Share by End-Users in 2016
-
Figure West USA Biosimilars Consumption Share by End-Users in 2021
-
Figure West USA Biosimilars Consumption Share by End-Users in 2027
-
Table South USA Biosimilars Consumption by Types from 2016 to 2027
-
Table South USA Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure South USA Biosimilars Consumption Share by Types in 2016
-
Figure South USA Biosimilars Consumption Share by Types in 2021
-
Figure South USA Biosimilars Consumption Share by Types in 2027
-
Table South USA Biosimilars Consumption by End-Users from 2016 to 2027
-
Table South USA Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure South USA Biosimilars Consumption Share by End-Users in 2016
-
Figure South USA Biosimilars Consumption Share by End-Users in 2021
-
Figure South USA Biosimilars Consumption Share by End-Users in 2027
-
Table Middle West USA Biosimilars Consumption by Types from 2016 to 2027
-
Table Middle West USA Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure Middle West USA Biosimilars Consumption Share by Types in 2016
-
Figure Middle West USA Biosimilars Consumption Share by Types in 2021
-
Figure Middle West USA Biosimilars Consumption Share by Types in 2027
-
Table Middle West USA Biosimilars Consumption by End-Users from 2016 to 2027
-
Table Middle West USA Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure Middle West USA Biosimilars Consumption Share by End-Users in 2016
-
Figure Middle West USA Biosimilars Consumption Share by End-Users in 2021
-
Figure Middle West USA Biosimilars Consumption Share by End-Users in 2027
-
Table Northeast USA Biosimilars Consumption by Types from 2016 to 2027
-
Table Northeast USA Biosimilars Consumption Share by Types from 2016 to 2027
-
Figure Northeast USA Biosimilars Consumption Share by Types in 2016
-
Figure Northeast USA Biosimilars Consumption Share by Types in 2021
-
Figure Northeast USA Biosimilars Consumption Share by Types in 2027
-
Table Northeast USA Biosimilars Consumption by End-Users from 2016 to 2027
-
Table Northeast USA Biosimilars Consumption Share by End-Users from 2016 to 2027
-
Figure Northeast USA Biosimilars Consumption Share by End-Users in 2016
-
Figure Northeast USA Biosimilars Consumption Share by End-Users in 2021
-
Figure Northeast USA Biosimilars Consumption Share by End-Users in 2027
-
Table Company Profile and Development Status of Sandoz International
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Sandoz International
-
Figure Sales and Growth Rate Analysis of Sandoz International
-
Figure Revenue and Market Share Analysis of Sandoz International
-
Table Product and Service Introduction of Sandoz International
-
Table Company Profile and Development Status of Mylan
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Mylan
-
Figure Sales and Growth Rate Analysis of Mylan
-
Figure Revenue and Market Share Analysis of Mylan
-
Table Product and Service Introduction of Mylan
-
Table Company Profile and Development Status of Hospira
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Hospira
-
Figure Sales and Growth Rate Analysis of Hospira
-
Figure Revenue and Market Share Analysis of Hospira
-
Table Product and Service Introduction of Hospira
-
Table Company Profile and Development Status of Roche Diagnostics
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Roche Diagnostics
-
Figure Sales and Growth Rate Analysis of Roche Diagnostics
-
Figure Revenue and Market Share Analysis of Roche Diagnostics
-
Table Product and Service Introduction of Roche Diagnostics
-
Table Company Profile and Development Status of Biocon
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Biocon
-
Figure Sales and Growth Rate Analysis of Biocon
-
Figure Revenue and Market Share Analysis of Biocon
-
Table Product and Service Introduction of Biocon
-
Table Company Profile and Development Status of Amgen
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Amgen
-
Figure Sales and Growth Rate Analysis of Amgen
-
Figure Revenue and Market Share Analysis of Amgen
-
Table Product and Service Introduction of Amgen
-
Table Company Profile and Development Status of Celltrion
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Celltrion
-
Figure Sales and Growth Rate Analysis of Celltrion
-
Figure Revenue and Market Share Analysis of Celltrion
-
Table Product and Service Introduction of Celltrion
-
Table Company Profile and Development Status of Merck KGaA
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Merck KGaA
-
Figure Sales and Growth Rate Analysis of Merck KGaA
-
Figure Revenue and Market Share Analysis of Merck KGaA
-
Table Product and Service Introduction of Merck KGaA
-
Table Company Profile and Development Status of Teva Pharmaceutical
-
Table Sales, Revenue, Sales Price and Gross Margin Analysis of Teva Pharmaceutical
-
Figure Sales and Growth Rate Analysis of Teva Pharmaceutical
-
Figure Revenue and Market Share Analysis of Teva Pharmaceutical
-
Table Product and Service Introduction of Teva Pharmaceutical
-
